Leslie Alexandre Is New CEO of Washington State’s Biotech Trade Group

Life Science Washington has named Leslie Alexandre as its new president and CEO. Her previous jobs include CEO of the North Carolina Biotechnology Center. Known until recently as the Washington Biotechnology & Biomedical Association, the trade group works in a state where government has been unfriendly of late to its constituents. The legislature last year pulled the plug on the modest Life Sciences Discovery Fund as well as an R&D tax credit. Two months later, LSW president and CEO Chris Rivera stepped down after six years with the group. Alexandre was born in Washington state, according to a press release. She starts at the end of May.

Author: Alex Lash

I've spent nearly all my working life as a journalist. I covered the rise and fall of the dot-com era in the second half of the 1990s, then switched to life sciences in the new millennium. I've written about the strategy, financing and scientific breakthroughs of biotech for The Deal, Elsevier's Start-Up, In Vivo and The Pink Sheet, and Xconomy.